| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice | Wu K.-C.; Lee C.-Y.; Chou F.-Y.; Chern Y.; CHUN-JUNG LIN | Brain, Behavior, and Immunity | 20 | 20 | |
| 1998 | Expression of type VI adenylyl cyclase in the central nervous system: Implication for a potential regulator of multiple signals in different neurotransmitter systems | Liu F.-C.; Wu G.-C.; SUNG-TSANG HSIEH ; Lai H.-L.; Wang H.-F.; Wang T.-W.; Chern Y. | FEBS Letters | 33 | 32 | |
| 2009 | Longitudinal evaluation of an N-Ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalus | MING-JEN LEE ; Chang C.-P.; Lee Y.-H.; Wu Y.-C.; Tseng H.-W.; Tung Y.-Y.; Wu M.-T.; Chen Y.-H.; LU-TING KUO ; Stephenson D.; Hung S.-L.; Wu J.-Y.; Chang C.; Chen Y.-T.; Chern Y. | PLoS ONE | 13 | 12 | |
| 2011 | A new drug design targeting the adenosinergic system for huntington's disease | Huang N.-K.; Lin J.-H.; Lin J.-T.; Lin C.-I.; Liu E.M.; CHUN-JUNG LIN ; Chen W.-P.; Shen Y.-C.; Chen H.-M.; Chen J.-B.; Lai H.-L.; Yang C.-W.; Chiang M.-C.; Wu Y.-S.; Chang C.; Chen J.-F.; Fang J.-M.; Lin Y.-L.; Chern Y. | PLoS ONE | 72 | 63 | |
| 2017 | The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway | Wu Y.-S.; Chen C.-C.; Chien C.-L.; Lai H.-L.; Jiang S.-T.; Chen Y.-C.; LING-PING LAI ; Hsiao W.-F.; WEN-PIN CHEN ; Chern Y. | Journal of Biomedical Science | 10 | 10 |
